Literature DB >> 8915473

Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey.

K Page-Shafer1, G N Delorenze, W A Satariano, W Winkelstein.   

Abstract

The course of disease associated with infection with the human immunodeficiency virus varies widely. Some patients deteriorate rapidly, while others live for years, even after an illness that defines the acquired immunodeficiency syndrome (AIDS). In this study, comorbidity, or the presence of concurrent health problems, was investigated prospectively as a possible co-factor for different rates of decline in 395 homosexual/bisexual men in the San Francisco Men's Health Study (SFMHS) who were infected with the human immunodeficiency virus (HIV). Comorbidity data obtained from baseline interviews included both chronic and infectious diseases as well as depression. Smoking, alcohol, and drug use were also examined. The most prevalent comorbid conditions were sexually transmitted diseases (90%) and hepatitis B infection (76%). Most chronic and acute concurrent health conditions were not significant discrete predictors of survival to AIDS or death after controlling for immune status and markers of disease progression. Significantly, other risk factors (e.g., depression and smoking) were found to be associated with more rapid progression. Men with symptoms of depression had a higher risk of progression of AIDS diagnosis; the relative hazard (RH) was 1.4 (95% confidence interval [CI], 1.00-2.08); smoking was associated with higher risk of death (RH, 1.6; 95% CI, 1.20-2.17). Older age was marginally associated with poorer survival to death. No associations were found between survival and alcohol and drug use.

Entities:  

Mesh:

Year:  1996        PMID: 8915473     DOI: 10.1016/s1047-2797(96)00064-6

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  50 in total

1.  The HIV Epidemic Among Individuals with Mental Illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

2.  Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial.

Authors:  Alexander C Tsai; Dan H Karasic; Gwendolyn P Hammer; Edwin D Charlebois; Kathy Ragland; Andrew R Moss; James L Sorensen; James W Dilley; David R Bangsberg
Journal:  Am J Public Health       Date:  2012-06-21       Impact factor: 9.308

3.  Childhood sexual abuse and depression in Latino men who have sex with men: Does resilience protect against nonadherence to antiretroviral therapy?

Authors:  John A Sauceda; John S Wiebe; Jane M Simoni
Journal:  J Health Psychol       Date:  2014-08-25

Review 4.  The HIV epidemic among individuals with mental illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

5.  Drug Use Mediates the Relationship Between Depressive Symptoms and Adherence to ART Among Recently Incarcerated People Living with HIV.

Authors:  Lauren M Hill; Carol E Golin; Nisha C Gottfredson; Brian W Pence; Bethany DiPrete; Jessica Carda-Auten; Jennifer S Groves; Sonia Napravnik; David Wohl; Kevin Knight; Patrick M Flynn
Journal:  AIDS Behav       Date:  2019-08

Review 6.  Review of the literature: integrating psychoneuroimmunology into pediatric chronic illness interventions.

Authors:  Jack H Nassau; Karen Tien; Gregory K Fritz
Journal:  J Pediatr Psychol       Date:  2007-09-10

Review 7.  Smoking Cessation for People Living With HIV/AIDS: A Literature Review and Synthesis.

Authors:  David M Ledgerwood; Russell Yskes
Journal:  Nicotine Tob Res       Date:  2016-05-31       Impact factor: 4.244

8.  Improvements in health-related quality of life following a group intervention for coping with AIDS-bereavement among HIV-infected men and women.

Authors:  Kathleen J Sikkema; Nathan B Hansen; Christina S Meade; Arlene Kochman; Rachel S Lee
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

9.  A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.

Authors:  Steven A Safren; Conall O'Cleirigh; Judy Y Tan; Sudha R Raminani; Laura C Reilly; Michael W Otto; Kenneth H Mayer
Journal:  Health Psychol       Date:  2009-01       Impact factor: 4.267

10.  Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis.

Authors:  Nancy L Sin; M Robin DiMatteo
Journal:  Ann Behav Med       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.